New Trial to Test Implantable Pacemaker for Serious Depression
(NEW YORK)Researchers at 20 leading medical centers in the US are testing a pacemaker-like device that may ease the symptoms of depression. Cyberonics, Inc., the device manufacturer, is currently awaiting approval form the Food and Drug Administration to begin clinical trials. The implanted device will stimulate a nerve that runs down the side of the neck. The nerve will be stimulated for 30 seconds, stop for 5 minutes, and begin again. Side effects of the stimulation include voice change, a sense that something is in the patient's mouth, and difficulty breathing during vigorous activity. For more information visit www.abcnews.com.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
